Pro-biotik
Natural health product licensed in Canada
- Other names
- 15 billion CFU, 5 Critical Therapeutic Strains, Shelf Stable with a minimum 15 Billion CFU, Non-Dairy
- Licence holder
- CanPrev Natural Health Products Ltd
- NPN or DIN-HM
- 80020819
- Status
- Active licence
- Licence date
- 19 July 2010
- Revision date
- 10 December 2025
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Lactobacillus acidophilus Source : HA-122 | 1.5 Milliards d'UFC | Not calculated |
| Lactobacillus acidophilus Source : Lactobacillus acidophilus | 1.5 Milliards d'UFC | Not calculated |
| Bifidobacterium bifidum Source : Bifidobacterium bifidum | 2.25 Milliards d'UFC | Not calculated |
| Bifidobacterium bifidum Source : HA-132 | 2.25 Milliards d'UFC | Not calculated |
| Bifidobacterium bifidum Source : Cellule entière | 2.25 Milliards d'UFC | Not calculated |
| Bifidobacterium bifidum Source : Bifidobacterium bifidum | 41.45 mg | Not calculated |
| Bifidobacterium bifidum Source : HA-132 | 41.45 mg | Not calculated |
| Bifidobacterium bifidum Source : Cellule entière | 41.45 mg | Not calculated |
| Lacticaseibacillus rhamnosus Source : HA-111 | 4.05 Milliards d'UFC | Not calculated |
| Lacticaseibacillus rhamnosus Source : Cellule entière | 4.05 Milliards d'UFC | Not calculated |
| Lacticaseibacillus rhamnosus Source : Lactobacillus rhamnosus | 4.05 Milliards d'UFC | Not calculated |
| Lacticaseibacillus rhamnosus Source : HA-111 | 64.43 mg | Not calculated |
| Lacticaseibacillus rhamnosus Source : Cellule entière | 64.43 mg | Not calculated |
| Lacticaseibacillus rhamnosus Source : Lactobacillus rhamnosus | 64.43 mg | Not calculated |
Non-medicinal ingredients
Fécule de pomme de terre, Fatty Acids Blend, Vitamine C, Hypromellose, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1 Capsule ; maximum: 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Probiotic that contributes to a natural healthy gut flora
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80020819
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.